After two months in the basement, we've seen a strong Bitcoin comeback that looks here to stay.

The crypto leader has found solid support at current prices, and is looking for the easiest path higher right now.

Bill Patalon talked with crypto expert Dave Zeiler on what investors need to know and what they need to do next...

The extreme recent volatility in cryptocurrencies, particularly Bitcoin, has investors wondering how to play crypto.

But there's only one action to take amidst the selloff: Buy, buy, buy...

Coinbase's massive IPO means cryptocurrencies have "officially" arrived on Wall Street.

It's an extremely bullish development for Bitcoin, but... investors everywhere want to know about the exchange's stock itself - "Should I buy Coinbase?"

Here's what you need to know...

Our Bill Patalon recently had a conversation with Money Morning's Director of Cannabis Investing Research, Don Yocham, about the monster rally in cannabis stocks sparked by the Democratic sweep of the White House and Congress.

He's sharing all the critical points of their chat with you, plus a winning cannabis play...

There's a "New Cold War" underway right now, and it's heating up.

Investors can't afford to ignore a $2 trillion global business: Defense.

And understanding where defense dollars will be spent will help you zero in on the winners in the "New Arms Race" - while also avoiding sectors and firms that'll be left behind.

Here's how to get started....

China’s recently adopted an anti-innovation stance with strict implications on its businesses, such as e-commerce giant Alibaba.

But that does NOT mean to dump Alibaba shares.

Instead, Bill Patalon will have us cashing in on this “one-stock wealth machine” no matter what China does next….

Back on Aug. 20, a U.S. Air Force pilot climbed into an F-16 "simulator" - in essence, a digital copy that does everything a real Lockheed Martin Fighting Falcon can do - and squared off in a "dogfight" against an artificial intelligence robot.

The result: The AI robot shot the human pilot down in flames.

Digitally speaking, of course.

The shoot-down of a human F-16 pilot was part of a multi-day dogfight competition sponsored by the Defense Advanced Research Projects Agency (DARPA). In fact, it played out in the grand finale of that DARPA "Air Combat Evolution" (ACE) competition - and meant that an AI "algorithm" was crowned as champ.

A robot is America's Top Gun.

It's a next key step in the "Drones Revolution" I've been chronicling for my Private Briefing subscribers.

And for investors like you, it means a hefty "wealth window" has been pushed wide open.

We're talking total "Blue Sky" profits... Full Story

"Lead, follow, or get out of the way."

This is one of those well-known aphorisms that's been around forever - though its originator is unknown.

Truth be told, it doesn't matter who said it first. It's a great bit of advice.

Especially as we interpret it.

In our investment work here at Money Morning, we always seek to lead Wall Street and the rest of the packrat investment crowd.

We never follow, especially since "the crowd" tends to be indecisive, late to the gun - or flat out wrong.

And we always get out of the way - sidestepping the dust-rising thump that's an inevitable result of the miscues and sins of the Wall Street Goliath.

It's a simple formula. And a successful one.

And it's the reason we keep outperforming "the crowd."

Like the 2,067% gain on biotech Galapagos NV, the very first stock I recommended on the very first day I published my Member-based service, Private Briefing, back in August 2011.

My readers also pulled down peak gains of more than 2,892% in Nvidia, 2,828% in Advanced Micro Devices, 818% in biotech buyout Pharmacyclics, and more.

Today, I've decided to share my latest insight on one of my big biotech winners with Money Morning readers because the opportunity is too good to keep to ourselves. And since my colleague Michael Robinson recently talked about 2020's record-crushing biotech IPOs, it's the perfect time to share this.

The company I'm showing you today is essential to biotech stocks. It's a "biotech-enabler" that's zoomed 1,755% since I first told my readers about it back in June 2013.

In 2013, it was trading at $8.14.

It closed July 30 at $151.25 - not long after Investor's Business Daily said the stock had entered a "Buy Zone."

True, but where were they seven years and 1,755% ago?

Of course, what's important now is what comes next - and it's clear this stock's run isn't over... Full Story

Bill recommended this "value" stock to his subscribers way back in 2013, but Wall Street is just catching on. If you were following along, you're way ahead of Wall Street.

And even if you weren't, that's okay, too, because it's not too late to get in on this stock.

Some shady financial practices have inflated the stock prices in this sector, but this one strategy weeds out the sick companies from the healthy.

In late 2016, the world's greatest stock picker (Bill Patalon to his friends) reported on the "IPO ice age," with a noticeable dearth of profitable IPOs, especially compared with the boom years of 2013 to 2015 when, depending on the year, anywhere from 170 to 275 companies listed.

But Bill also predicted that the "ice age" would end with a ferocious warm-up, and it looks like he was, literally, on the money there.

Not only are there the four cannabis IPOs that could potentially create $12 billion in new wealth within the next few weeks (more on those here), but we're also looking at a massive year from new tech companies; the next generation of market leaders, like Uber.

That company could absolutely dwarf the $25 billion Alibaba debut, which was the richest in history... so far.

But investors - regular people who don't have $500 million in capital to throw around - have to be careful with these "market events." If we go about it the right way, "outsiders" like you and I can play them for profit, but it's worth bearing in mind that IPOs are predominantly designed for underwriters and corporate principals to cash in.

Our No. 1 stock picker is back again with an industry filled with opportunity - and one firm that is dominating the competition.

To help get you set up for profitable crypto investing this year, Money Morning Executive Editor, Bill Patalon, sat down with our legendary cryptocurrency expert here at Money Morning, David Zeiler.

Goldcorp just announced it would host next year's #DisruptMining innovation expo.

The Dow Jones Industrial Average is trending up this morning thanks to highly anticipated earnings reports from Wal-Mart Stores (NYSE: WMT), which is up 3.3% already today.

Dow Jones futures today are up 68 points ahead of trading, but a Republican defector from the Senate's tax cut bill could threaten gains.

The Dow Jones today is already down 100 points in pre-market hours as the retail ice age rears its head again...

Fortunately, the retail ice age is creating a profit opportunity for savvy investors.

The Dow Jones today might not reach a fourth consecutive day of a record-high open thanks to Chipotle Mexican Grill (NYSE: CMG)...

Dow Jones futures are down 11 points this morning after Chipotle fell well short of earnings expectations yesterday.

The Dow Jones today will continue its record-breaking run, as futures are already up 140 points before the bell.

The Dow Jones will open for a third-consecutive record-high today as a positive earnings season rolls on.

The Dow Jones Industrial Average today is set to open above 23,000 points for the first time in its history...

Dow Jones futures are up 92 points in pre-trading hours as a positive earnings season continues today.

GE is in dire need of some momentum.

If CEO John Flannery refocuses his efforts on this key component of GE's business, he could save the company.

The Dow Jones Industrial Average is down 16 points in pre-market hours today as investors prepare for a tumultuous secession vote in Spain this weekend...

Catalonian secession or violence in the region could send European stocks plunging, and American stock markets won't be immune.